Artificial Intelligence is Transforming Oncology Clinical Operations and Treatment Planning
Dr. Margarita Racsa, co-chair of the American College of Radiology artificial intelligence subcommittee, evaluated the transformative impacts of artificial intelligence on tumor board preparations, electronic health records, and clinical trials.
How artificial intelligence is transforming clinical operations in oncology, from tumor board preparations to treatment planning, has been explained. Experts state that the integration is guided by a three-phase framework.
AI Transformation in Clinical Operations
Artificial intelligence is bringing measurable changes to clinical operations in oncology by accelerating tumor board preparations, optimizing treatment planning, and opening new pathways for access to clinical trials.
Three-Phase Tumor Board Framework
Dr. Margarita Racsa outlined a three-phase framework for integrating artificial intelligence into tumor board discussions, which includes pre-meeting chart preparation, real-time alignment with guidelines during the meeting, and the documentation of patient-friendly summaries post-meeting.
The Importance of Electronic Health Records
It was emphasized that a unified electronic health record represents the single greatest use case providing benefit for both patients and physicians, and that artificial intelligence holds the potential to achieve this.
Future Transformative Impacts
Over the next three to five years, AI-powered clinical trial enrollment, expanded access for rural areas, and unified electronic health records are expected to have the most transformative impacts.